Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.49 USD | +0.61% | +4.20% | +2.43% |
Jun. 04 | Pfizer: article on Lyme vaccine in The Lancet | CF |
Jun. 04 | Pfizer Partners with Abu Dhabi to Advance Research on Sickle Cell Disease | MT |
Chart calendar Pfizer, Inc.
Upcoming events on Pfizer, Inc.
Past events on Pfizer, Inc.
2024-06-03 02:45 pm | American Society of Clinical Oncology Meeting - Abstract No: 3509 |
2024-06-03 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: 5531 |
2024-06-03 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: 7522 |
2024-06-03 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: 7053 |
2024-06-03 09:00 am | American Society of Clinical Oncology Meeting - Abstract No: 4503 |
2024-06-03 09:00 am | American Society of Clinical Oncology Meeting - Abstract No: 4502 |
2024-06-02 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: 4563 |
2024-06-02 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: 4562 |
2024-06-02 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: 5063 |
2024-06-02 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: 5061 |
2024-06-02 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: 5021 |
2024-06-02 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: 1105 |
2024-06-02 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: 1111 |
2024-06-01 05:30 pm | American Society of Clinical Oncology Meeting - Abstract No: 8521 |
2024-06-01 04:00 pm | American Society of Clinical Oncology Meeting - Abstract No: LBA7005 |
2024-06-01 04:00 pm | American Society of Clinical Oncology Meeting - Abstract No: 5005 |
2024-06-01 04:00 pm | American Society of Clinical Oncology Meeting - Abstract No: 3006 |
2024-06-01 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: 3108 |
2024-05-31 03:45 pm | American Society of Clinical Oncology Meeting - Abstract No: LBA8503 |
2024-05-08 | Ex-dividend day |
Past dividends on Pfizer, Inc.
2024-05-08 | Quarterly 0.42 USD |
2024-01-24 | Quarterly 0.42 USD |
2023-11-08 | Quarterly 0.41 USD |
2023-07-26 | Quarterly 0.41 USD |
2023-05-10 | Quarterly 0.41 USD |
2023-01-25 | Quarterly 0.41 USD |
2022-11-02 | Quarterly 0.4 USD |
2022-07-27 | Quarterly 0.4 USD |
2022-05-11 | Quarterly 0.4 USD |
2022-01-26 | Quarterly 0.4 USD |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 51 750 51 807 -0.11% | 41 908 48 014 -12.72% | 81 288 81 781 -0.6% | 100 330 100 373 -0.04% | 58 496 59 105 -1.03% | 60 504 |
EBITDA Million USD | Released Forecast Spread | 21 097 22 824 -7.57% | 17 801 21 398 -16.81% | 25 426 29 444 -13.65% | 42 336 44 597 -5.07% | 15 590 11 249 38.59% | 21 202 |
EBIT Million USD | Released Forecast Spread | 19 420 19 883 -2.33% | 13 024 17 362 -24.99% | 20 235 26 662 -24.11% | 37 272 40 403 -7.75% | 9 300 8 509 9.3% | 16 835 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 17 682 22 426 -21.15% | 7 497 13 166 -43.06% | 24 311 19 569 24.23% | 34 729 39 058 -11.08% | 1 058 2 301 -54.02% | 11 020 |
Net income Million USD | Released Forecast Spread | 16 273 19 053 -14.59% | 9 616 16 066 -40.15% | 21 979 22 567 -2.6% | 31 372 33 053 -5.09% | 2 119 3 040 -30.29% | 6 882 |
EPS USD | Released Forecast Spread | 2,87 3,40 -15.62% | 1,71 3,07 -44.24% | 3,85 3,89 -0.9% | 5,47 5,85 -6.45% | 0,37 0,72 -48.44% | 1,31 |
Announcement Date | 28/01/20 | 02/02/21 | 08/02/22 | 31/01/23 | 30/01/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 25 661 24 734 3.75% | 27 742 26 199 5.89% | 22 638 21 091 7.33% | 24 290 24 393 -0.42% | 18 282 16 488 10.88% | 12 734 13 398 -4.96% | 13 232 13 429 -1.47% | 14 249 14 396 -1.02% | 14 879 13 923 6.87% | 13 053 | 14 851 | 17 769 | 15 680 | 13 725 |
EBITDA Million USD | Released Forecast Spread | 11 135 13 710 -18.78% | 13 583 12 434 9.25% | 10 325 10 332 -0.06% | 6 772 7 436 -8.92% | 7 857 7 513 4.58% | 4 925 4 000 23.13% | -1 244 -1 511 17.64% | 1 340 -1 298 203.24% | 4 403 | 3 759 | 4 681 | 4 537 | ||
EBIT Million USD | Released Forecast Spread | 9 948 9 738 2.16% | 12 408 11 055 12.24% | 9 142 9 092 0.55% | 5 253 6 886 -23.71% | 6 370 6 471 -1.56% | 3 319 3 634 -8.68% | -1 625 -1 827 11.07% | -330 -1 404 76.5% | 5 912 3 667 61.24% | 3 423 | 3 804 | 3 977 | ||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 9 050 | 5 231 7 425 -29.55% | -3 352 2 207 -251.88% | -4 129 -3 139 -31.54% | 3 421 2 992 14.34% | 1 962 | 2 926 | 3 380 | ||||||
Net income Million USD | Released Forecast Spread | 7 864 8 418 -6.58% | 9 906 9 799 1.09% | 8 608 7 631 12.8% | 4 995 5 667 -11.86% | 5 543 4 495 23.31% | 2 327 | -2 382 -3 241 26.49% | -3 369 -2 371 -42.12% | 3 115 1 951 59.69% | 1 451 | 1 957 | 2 545 | ||
EPS USD | Released Forecast Spread | 1,37 1,60 -14.17% | 1,73 1,64 5.73% | 1,51 1,37 10.21% | 0,87 0,69 25.48% | 0,97 0,85 14.79% | 0,41 | -0,42 -0,51 16.83% | -0,60 -0,43 -41.06% | 0,55 0,34 61.01% | 0,24 | 0,35 | 0,45 | ||
Announcement Date | 03/05/22 | 28/07/22 | 01/11/22 | 31/01/23 | 02/05/23 | 01/08/23 | 31/10/23 | 30/01/24 | 01/05/24 | - | - | - | - | - |
Past sector events for Pfizer, Inc.
2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
2024-05-29 05:26 am | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
2024-05-29 04:44 am | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
2024-05-29 04:10 am | IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release |
2024-05-28 | PFIZER LIMITED: Q4 2024 Earnings Release |
2024-05-27 | DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release |
2024-05-27 08:10 am | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PFE Stock
- Calendar Pfizer, Inc.